Postmastectomy RT decision for lymph node negative patients: Turkish radiation oncology society

Basit Öğe Kaydı
dc.contributor.authorAltınok, Ayşe
dc.contributor.authorGürsel, Bilge
dc.contributor.authorErgen, A.
dc.contributor.authorAlanyalı, Senem
dc.contributor.authorÖzsaran, Zeynep
dc.contributor.authorAy, Ahmet
dc.contributor.authorMetcalfe, Evrim
dc.contributor.authorAkmansu, Müge
dc.contributor.authorTepetam, Hüseyin
dc.contributor.authorAltınok, Pelin
dc.contributor.authorAltmışdörtoğlu, Özgür
dc.contributor.authorSerarslan, Alparslan
dc.contributor.authorBese, Nuran
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:50:43Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:50:43Z
dc.date.issued2018
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı
dc.description37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) -- APR 20-24, 2018 -- Barcelona, SPAIN
dc.descriptionWOS: 000438676100060
dc.description.abstractEarly Breast Cancer Trialists’ Collaborative Group meta analyses have shown that postmastectomy radiotherapy (PMRT) had no significant effect on locoregional recurrence (LRR), overall recurrence or breast cancer mortality for patients without lymph node metastases. On the other hand it has also been shown that the risk of developing LRR is rising up to 15% or more for women in the presence of two or more adverse factors even though there is no lymph node involvement. In this study, PMRT indications were evaluated in 12 centers, overall Turkey to observe and document the decision making after mastectomy.
dc.description.sponsorshipEuropean Society for Radiotherapy and Oncologyen_US
dc.identifier.citationAltınok, A., Gürsel, B., Ergen, A.., Alanyalı, S., Özsaran, Z., Ay, A. ... Bese, N. (2018). Postmastectomy RT decision for lymph node negative patients: Turkish radiation oncology society. 37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) içinde (S696-S697. ss.). Barcelona, Spain, April 20-24 2018. https://dx.doi.org/10.1016/S0167-8140(18)31572-X
dc.identifier.doi10.1016/S0167-8140(18)31572-X
dc.identifier.endpageS697
dc.identifier.issn0167-8140
dc.identifier.issn1879-0887
dc.identifier.issueSupplement: 1
dc.identifier.startpageS696
dc.identifier.urihttps://dx.doi.org/10.1016/S0167-8140(18)31572-X
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2055
dc.identifier.volume127
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartof37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titlePostmastectomy RT decision for lymph node negative patients: Turkish radiation oncology society
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Altınok, A..pdf
Boyut:
608.39 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Bildiri Koleksiyonu